“…To our knowledge, only a limited number of functional AhR-binding sites have been identified, mostly within the promoter regions of AhR-regulated genes (Sun et al, 2004;Tijet et al, 2006), including Cyp1A1 (Cytochrome P450, 1A1) (Denison et al, 1988;Lusska et al, 1993), Cyp1A2 (Cytochrome P450, 1A2) (Quattrochi et al, 1998;Sogawa et al, 2004), Cyp1B1 (Cytochrome P450, 1B1) (Eltom et al, 1999), Nqo1 (NAD(P)H: quinone oxidoreductase 1) (Favreau and Pickett, 1991), Ugt1A1 (UDPglucuronosyltransferase 1A1) (Emi et al, 1996), Gsta1 (Glutathione S-transferase Ya) (Pimental et al, 1993), Aldh3A1 (Aldehyde dehydrogenase 3A1) (Boesch et al, 1999), Nrf2 (NF-E2 p45-related factor) (Miao et al, 2005), Pon1 (Paraoxonase 1) (Gouedard et al, 2004), Cyp19A1 (P450 aromatase) (Baba et al, 2005), c-myc (Yang et al, 2005), Cyp2S1 (Cytochrome P450, 2S1) (Rivera et al, 2007), and Cyp2A5 (Cytochrome P450, 2A5) (Arpiainen et al, 2005); Cyp1A1 and Cyp1B1 being studied most extensively as model AhR-induced genes. Previous gene expression profiling by the DNA microarray technique in mouse hepatoma Hepa-1c1c7 cells stimulated with TCDD revealed that at least 285 genes exhibited obvious changes in their expression (Dere et al, 2006), but experimental genome-wide research for direct AhR-target genes has not been carried out so far.…”